Search
for
Sort by
Research 31–60 of 829
- Female Pelvic Conditions: Polycystic Ovary Syndrome.
- SAT-223 Insights into Ovarian Hyperandrogenism: Lessons from Two Unusual Cases
- Neural substrates of the emotional negativity bias as revealed by haemodynamic data
- The treatment of polycystic ovary syndrome.
- Pharmacological Control of Reproduction in the Dog and Cat
- Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH
- Hyperandrogenic eumenorrheic NON-PCOS women versus women with PCOS after the GnRH-agonist stimulation test preceded by suppression of adrenal steroidogenesis with dexamethasone
- Physiology of the Hypothalamic Pituitary Gonadal Axis in the Male
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis
- Recommendations of endocrine treatment for patients with gender dysphoria
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Slow progress in prostate cancer
- The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology
- Hormonal treatment of acne vulgaris: an update
- Acupuncture in Polycystic Ovary Syndrome: Potential and Challenge
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- Ciclosporin-Induced Generalised Hypertrichosis in a Transgender Woman Receiving Testosterone Blockers
- Reporting on Adverse Clinical Events
- GLP-1 Receptor Analogs: Evidence Linking to Effect on Metabolic and Reproductive Functions in Patients with PCOS and Obesity
- Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review
- Impact of Medical Castration on Malignant Arrhythmias in Patients With Prostate Cancer
- News & Notes
- Diseases of the Canine Prostate Gland
- Neuroendocrine Determinants of Polycystic Ovary Syndrome
- Phase 2, double-blind, randomized, placebo-controlled study of the safety and efficacy of elagolix in women with polycystic ovary syndrome
- Novel anti-Mullerian hormone receptor 2 binding peptide prevents chemotherapy-related ovarian follicle loss in a mouse model
- The Physiological Impact of Melatonin, Its Effect on the Course of Diseases and Their Therapy and the Effect of Magnetic Fields on Melatonin Secretion—Potential Common Pathways of Influence
- Clinical applications of antiandrogens
- Cardiovascular effects of hormone therapy for prostate cancer